BetterLife Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Market Capitalization	10	17	9	13	17	70
Market Cap Growth	-28.35%	91.79%	-35.00%	-23.05%	-75.11%	187.64%
Enterprise Value	14	21	11	17	15	73
Last Close Price	0.06	0.13	0.09	0.15	0.20	1.36
PB Ratio	-1.56	-2.26	-1.13	-1.77	-4.47	-15.11
Debt / Equity Ratio	-0.12	-0.18	-0.07	-0.02	-0.08	-0.11
Net Debt / Equity Ratio	-0.12	-0.18	-0.07	-0.02	-0.04	-0.07
Net Debt / EBITDA Ratio	-	-	-0.16	-0.02	-0.01	-0.04
Net Debt / FCF Ratio	-3.43	-0.65	-0.21	-0.12	-0.01	-0.05
Quick Ratio	0.00	0.00	0.01	0.00	0.12	0.12
Current Ratio	0.05	0.03	0.04	0.01	0.28	0.23
Return on Assets (ROA)	-445.30%	-1074.42%	-1004.42%	-936.16%	-493.00%	-103.39%
Return on Capital Employed (ROCE)	33.00%	64.60%	45.70%	130.90%	334.40%	177.50%
Earnings Yield	-19.21%	-21.15%	-33.29%	-67.53%	-70.08%	-52.15%
FCF Yield	-	-12.15%	-28.49%	-11.26%	-64.57%	-10.29%
Buyback Yield / Dilution	-16.79%	-13.34%	-26.25%	-14.70%	-179.24%	-79.75%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.